Preventing and Correcting Communicable and Non-Communicable Chronic Disease via Amlexanox – Dual ‘No-Nonsense’ and Inflammatory Axis Targeting

Indoor Air Quality and Severity of COVID-19: Where Communicable and Non-communicable Preventive Measures Meet

Non-communicable disease surveillance and population surveys.

Biosecurity and Non-Communicable Diseases

Although the traditional biosecurity paradigm is concerned with the deliberate misuse of biological agents, in recent years national security strategies have widened in scope to address a much wider spectrum of biological threats. This expanding remit, partly spurred by the high-profile epidemics of the early 2000s, still does not include conditions that have been traditionally conceived as non...

The environment-pathogen-host axis in communicable and non-communicable diseases: recent advances in experimental and clinical research.

Allergies and autoimmune diseases are spreading worldwide. Control of infections, on the other hand, remains an issue, even in the post-antibiotic era. Chronic or poorly controlled infections occur in immune compromised individuals such as HIV patients, hospitalized patients exposed to multi-resistant bacteria, or patients on immunosuppressive treatment. They may become an even more emerging is...

Communicable Disease and Public Health

Current UK policy on immunisation for tetanus has changed in the light of evidence that five doses of vaccine probably provides sufficient protection as long as high-risk wounds are managed with tetanus immunoglobulin. This paper reviews the evidence base for tetanus immunisation policy in England and Wales: the epidemiology of tetanus, vaccination coverage and response to tetanus toxoid, and p...